IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
6.90
-0.15 (-2.13%)
Dec 20, 2024, 4:00 PM EST - Market closed
IGM Biosciences Market Cap
IGM Biosciences has a market cap or net worth of $410.30 million as of December 20, 2024. Its market cap has increased by 0.38% in one year.
Market Cap
410.30M
Enterprise Value
237.37M
1-Year Change
0.38%
Ranking
Category
Stock Price
$6.90
Market Cap Chart
Since September 18, 2019, IGM Biosciences's market cap has decreased from $702.07M to $410.30M, a decrease of -41.56%. That is a compound annual growth rate of -9.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 410.30M | -15.45% |
| Dec 29, 2023 | 485.25M | -33.39% |
| Dec 30, 2022 | 728.48M | -23.49% |
| Dec 31, 2021 | 952.10M | -66.22% |
| Dec 31, 2020 | 2.82B | 141.87% |
| Dec 31, 2019 | 1.17B | 65.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Esperion Therapeutics | 428.55M |
| ProKidney | 425.83M |
| Health Catalyst | 424.11M |
| Sonida Senior Living | 424.01M |
| OmniAb | 423.54M |
| Codexis | 416.65M |
| Organogenesis Holdings | 412.31M |
| Tactile Systems Technology | 406.75M |